Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.7 |
mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |